自体周围神经组织植入Meynert基底核联合脑深部电刺激治疗帕金森病:两年安全性、可行性与临床反应报告
本研究纳入7例帕金森病患者,在双侧苍白球内侧部脑深部电刺激电极植入的同时,单侧将自体腓肠神经移植物植入Meynert基底核;术后每6个月随访。结果显示该手术安全可行,未出现与研究干预相关的严重不良事件,神经心理表现与未接受移植的常规DBS患者相似,运动与生活质量评分轻度变差,总体非运动评分轻度改善。
要点
- 单侧Meynert基底核自体周围神经组织移植未增加严重不良事件风险
- 神经心理表现与未移植的常规DBS患者相似,认知下降未超出晚期帕金森病常见水平
- 运动与生活质量轻度变差、非运动评分轻度改善,提示可能存在靶点特异性效应
核心结论
- 单侧Meynert基底核植入自体周围神经组织被判定为安全可行,未显著增加认知下降和痴呆风险,超出晚期帕金森病通常观察到的发生率。
- 研究靶向与运动症状无关的Meynert基底核,运动与生活质量评分的轻度进展提示周围神经组织支持可能具有靶点特异性临床效应。
- 作者认为这些发现支持开展进一步研究,包括采用适当对照组的更大规模研究。
研究设计与样本
- 研究为开放标签研究,共纳入7例帕金森病患者。
- 所有参与者接受双侧苍白球内侧部脑深部电刺激电极植入,并单侧将再生腓肠神经移植物植入Meynert基底核。
- 术后每6个月随访一次,临床结局指标包括神经心理、运动、非运动和生活质量评分。
主要发现
- 所有参与者完成6个月和12个月随访,5例完成24个月随访。
- 未出现与研究干预相关的严重不良事件。
- 神经心理表现结果与接受标准DBS手术而未植入移植物的患者相似。
- 运动和生活质量评分轻度变差,总体非运动评分轻度改善。
临床怎么用
- 该干预目前处于研究阶段,仅7例开放标签数据,尚不能作为常规临床推荐。
- 临床决策时应向患者说明其安全可行性信号与缺乏对照组、样本量小的局限。
局限性
- 研究为开放标签设计,样本量仅7例,24个月随访仅5例完成。
- 缺乏同期对照组,结论需更大规模、采用适当对照组的研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Parkinson's disease (PD) is characterized by both motor and nonmotor symptoms, including cognitive impairment. Neuronal loss in the nucleus basalis of Meynert (NBM) plays a role in the presentation of cognitive impairment in PD. The implantation of peripheral nerve tissue (PNT) might provide neuroprotective and regenerative capabilities and has shown promising open-label outcomes. The aim of this study was to investigate the safety, feasibility, and clinical outcomes of implanting PNT to the NBM in patients with PD. METHODS: Seven participants with PD underwent bilateral deep brain stimulation (DBS) electrode implantation to the globus pallidus internus plus unilateral PNT regenerating sural nerve graft to the NBM. Participants were monitored at 6-month intervals postoperatively. Clinical outcome measures included neuropsychological, motor, nonmotor, and quality of life ratings. RESULTS: All participants completed the 6- and 12-month visits and 5 completed the 24-month visit. There were no serious adverse events related to the study intervention. Neuropsychological performance results were similar to those of patients who underwent DBS standard-of-care procedures without graft implantation. Motor and quality of life ratings were slightly worse, with slight improvements in overall nonmotor scores. CONCLUSIONS: Unilateral implantation of PNT to the NBM was determined as a safe and feasible procedure such that it did not substantially increase the risk for cognitive decline and dementia beyond rates typically observed in late-stage PD. The current study targeted the NBM, an area not associated with motor symptoms, and the mild progression of motor and quality of life ratings suggest that PNT support might have target-specific clinical effects. These findings support the need for further research in this area, including larger studies that use appropriate control groups.
引用
- Ali S, Quintero JE, Richert M, et al. Implantation of autologous peripheral nerve tissue to the nucleus basalis of Meynert in patients with Parkinson's disease during deep brain stimulation surgery: a 2-year report of safety, feasibility, and clinical response. J Neurosurg. 2026. PMID: 42600181. doi:10.3171/2026.3.JNS251474
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。